Total Funding
72
71
Total FundingConvertible Note raised
Growth Score
-2 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
23707
SFA Therapeutics is a developer of drugs to treat chronic inflammatory diseases.
Robert Dickey: Chief Financial OfficerPast Role: Locus Pharmaceuticals, VP, Finance and CFO- Alla Arzumanyan: CDO and Co-FounderPast Role: Thomas Jefferson University, Adjunct Professor
About the Company
SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs.
Women Founded
